home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

244 rows where filing_period = "second_quarter", filing_year = 2012 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 244 ✖

filing_year 1

  • 2012 · 244 ✖

filing_period 1

  • second_quarter · 244 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1257730 CYBER SECURITY RESEARCH CONSULTANTS, LLC fca0d781-a28d-4d9c-9b57-72ee165a99ad Q2 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2012 second_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug reimportation from Canada Monitoring Protect IP ACT, Monitoring SOPA Monitoring FDA Reauthorization Act HOUSE OF REPRESENTATIVES,SENATE 21000   0 0 2012-07-02T15:00:11.417000-04:00
1258009 SHELTER ROCK STRATEGIES, LLC 3a18555e-1bc0-4e6a-bb51-f1d63e0668f6 Q2 SHELTER ROCK STRATEGIES, LLC 400772326 NEW YORK MEDICAL COLLEGE 2012 second_quarter PHA BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aid the client's proposal. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2012-07-03T13:38:10.217000-04:00
1258098 UNIVERSITY OF IOWA d38dbbed-253f-4ab8-a41a-f0a1eb5e397c Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2012 second_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research FDA User Fee Bill Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2012-07-03T16:59:14.913000-04:00
1258189 RED+BLUE STRATEGIES 90b07013-6ce7-43d9-963f-c9fbd26729ce Q2 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2012 second_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-05T11:09:34.033000-04:00
1258193 RED+BLUE STRATEGIES 616bb44d-53f1-45e5-a190-e34c2c1a14be 2A RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2012 second_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-07-05T11:10:35.127000-04:00
1258262 INJURED WORKERS PHARMACY 43d896e7-6a56-48af-a92d-b79c33545364 Q2 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2012 second_quarter PHA Transparency of Pharmacy Benefit Managers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshore and Harbor Workers Amendment Act of 2011 sponsored by Senator Isakson. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-05T13:49:07.670000-04:00
1258375 AMERICAN COLLEGE OF CLINICAL PHARMACY 8d8da5a7-ba19-4f0b-8d4d-e341a6483704 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2012 second_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61700 0 0 2012-07-05T15:08:09.390000-04:00
1258607 RED+BLUE STRATEGIES 1417d12b-9115-4cac-9d6e-5aa8c779b0e1 Q2 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2012 second_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. Issues related to the practice of giving coupons for certain prescription medications. S. 3187 - FDA Safety and Innovation Act - Issues related to supply chain safety, treatment of controlled substances and REMS policies. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-07-06T14:03:01.527000-04:00
1258659 RED+BLUE STRATEGIES ab80f880-f4d9-48a8-829a-c763c4b4a4db Q2 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2012 second_quarter PHA H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. S. 3187 - The FDA Safety and Innovation Act- specific work on antibiotic innovation, up and down stream supply chain issues, and medical device policies. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Related issues being considered in pending User Fee Reauthorization legislation. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-06T16:44:43.090000-04:00
1258693 AMERICAN AMBULANCE ASSOCIATION b8fe620c-082b-4c04-b79c-421d934e2189 Q2 AMERICAN AMBULANCE ASSOCIATION 56018 AMERICAN AMBULANCE ASSOCIATION 2012 second_quarter PHA Supported efforts to address the drug shortage issue in the Food and Drug Administration Safety and Innovation Act (S. 3187) as it pertains to emergency medical service providers. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   240000 0 0 2012-07-07T09:30:24.563000-04:00
1258778 NAHIGIAN STRATEGIES, LLC 028d0ba1-1b5b-43b8-9535-af9eefa30032 Q2 NAHIGIAN STRATEGIES, LLC 322897 TEVA PHARMACEUTICALS USA INC 2012 second_quarter PHA Generic pharmaceutical issues. Advocated for provisions related to the FDA user fee legislation.   30000   0 0 2012-07-09T08:33:58.870000-04:00
1259277 LONG TERM CARE PHARMACY ALLIANCE 6a7dc566-4717-462a-9219-16ee1bacb056 Q2 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2012 second_quarter PHA Medicare Part D Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2012-07-09T14:44:06.780000-04:00
1259835 HOLLAND & KNIGHT LLP 46aa986f-d9bf-4195-a22e-6b1574e7feb2 Q2 HOLLAND & KNIGHT LLP 18466 SAFECOR HEALTH, LLC 2012 second_quarter PHA Drug supply chain provisions in federal legislation; specifically S.3187, The Food & Drug Administration Safety & Innovation Act and H.R. 5651, The Food & Drug Administration Reform Act of 2012. Advocated for provisions recognizing the role of drug repackagers and against provisions to make certain hydrocodone products schedule 2 controlled substances. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-10T15:12:28.827000-04:00
1260608 HEARTLAND SOLUTIONS GROUP, INC. fa9e8e30-db77-442a-ba18-a2c8d567ef1f Q2 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2012 second_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. HOUSE OF REPRESENTATIVES,SENATE 41250   0 0 2012-07-11T15:55:50.380000-04:00
1260624 PARRY, ROMANI, DECONCINI & SYMMS 006f3c9b-d270-450d-9dc9-8f2b64e1c919 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2012 second_quarter PHA To provide incentives for new drug development. No specific bills pending. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2012-07-11T16:01:58.143000-04:00
1260631 THE OB-C GROUP, LLC c4e8038c-27ea-47f9-99d7-76bd09df9dad Q2 THE OB-C GROUP, LLC 29802 ELI LILLY 2012 second_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-11T16:07:03.750000-04:00
1260653 DENNY MILLER ASSOCIATES bdd45747-b59c-495d-8596-8f713efb7291 Q2 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2012 second_quarter PHA S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-11T16:22:16.397000-04:00
1260704 DUTKO WORLDWIDE, LLC a40a0370-b69b-43f7-9958-90d77142b90c Q2 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2012 second_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-11T17:34:49.167000-04:00
1260860 TAUZIN CONSULTANTS, LLC f87f2484-6678-45f8-8c02-9b62094936a9 Q2 TAUZIN CONSULTANTS, LLC 400671007 RESILIENT NETWORK SYSTEMS, INC. 2012 second_quarter PHA Cross-agency collaboration and information sharing for R&D, clinical trials, and recruitment Director of National Intelligence (ODNI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2012-07-12T09:59:11-04:00
1261005 ASSOCIATION FOR ACCESSIBLE MEDICINES 464adfd4-5853-4be0-9236-3e2889feaaa8 Q2 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2012 second_quarter PHA FY 2013 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, drug shortages, prescription drug abuse and generic drugs H.R.2182 Generating Antibiotic Incentives Now Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 H.R.3839 - Drug Shortage Prevention Act of 2012 H.R.3988 - Generic Drug and Biosimilar User Fee Act of 2012 H.R.3995 - Protecting Consumer Access to Generic Drugs Act of 2012 H.R.4332 - Generic Drug Application Review Fairness Act of 2012 H.R. 5651 - Food and Drug Administration Reform Act of 2012 S.44 Medicare Prescription Drug Negotiation Act S.296 and H.R.2245 Preserving Access to Life-Saving Medication Act S.373 Fair Prescription Drug Competition Act S.1584 - Drug Safety and Accountability Act of 2011 S.1734 - Generating Antibiotic Incentives Now Act of 2011 S.2295 - Patient Safety and Generic Labeling Improvement Act S.2516 - Food and Drug Administration Safety and Innovation Act S.3187 Food and Drug Administration Safety and Innovation Act Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR),White House Office   504925 0 0 2012-07-12T11:52:01.590000-04:00
1261185 NEW JERSEY HOSPITAL ASSOCIATION 96d9daaa-f721-4b4c-9af9-38d6f3ac7517 Q2 NEW JERSEY HOSPITAL ASSOCIATION 29128 NEW JERSEY HOSPITAL ASSOCIATION 2012 second_quarter PHA Support S. 3187, the Food and Drug Administration Safety and Innovation Act, which included industry supported provisions to help alleviate critical drug shortages. HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2012-07-12T15:18:37.647000-04:00
1261193 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 19911757-0d23-4ae0-a69d-ab6eac8987e4 Q2 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2012 second_quarter PHA the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507/H.R. 1925) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Prescription Drug User Fee Act (PDUFA) reauthorization legislation (H.R. 5651/S. 3187) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   117767 0 0 2012-07-12T15:22:41.100000-04:00
1261217 INDEPENDENT PHARMACY COOPERATIVE 48bf2391-07a1-4c00-884d-e0bc0603f138 Q2 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2012 second_quarter PHA CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. Potential prescription drug track-and-trace legislation. RxTEC National Average Drug Acuisition Cost (NADAC) implementation. Calculation and Process Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2012-07-12T15:51:49.337000-04:00
1261291 PARRY, ROMANI, DECONCINI & SYMMS e2fa8db2-aa81-42ad-9ace-ec874e6285b7 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2012 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T16:58:31.483000-04:00
1261300 PARRY, ROMANI, DECONCINI & SYMMS ef702ed0-4326-44a6-aabd-1688e8451258 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2012 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2012-07-12T17:05:35.747000-04:00
1261349 PARRY, ROMANI, DECONCINI & SYMMS bbf34b52-4b5b-4173-a16b-68ba45116eb9 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2012 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T17:25:57.753000-04:00
1261380 PARRY, ROMANI, DECONCINI & SYMMS 347c89ec-f95a-41a1-a32d-649aa6766f94 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2012 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Regulatory issues involving compounded 17P and compounded Avastin. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T17:33:07.937000-04:00
1261391 PARRY, ROMANI, DECONCINI & SYMMS 52b94dbf-16a3-4867-840f-7092121257d9 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2012 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Regulatory issues involving compounded 17P. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-07-12T17:41:15.013000-04:00
1261398 CAPITOL HILL CONSULTING GROUP 794f0916-a7b8-4184-8b0f-54add4ed88ac Q2 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2012 second_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) HOUSE OF REPRESENTATIVES,SENATE 32000   0 0 2012-07-12T17:44:17.667000-04:00
1261490 GREENBERG TRAURIG, LLP dbd716d0-cfac-4f01-882c-77b3b328754e Q2 GREENBERG TRAURIG, LLP 16896 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) 2012 second_quarter PHA Health care legislative and regulatory issues affecting independent community pharmacies. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) 30000   0 0 2012-07-13T07:21:24.173000-04:00
1261551 APOTEX CORP. 64548c82-fb2f-4cc0-a480-b3629f6e4a03 Q2 APOTEX CORP. 310973 APOTEX CORP. 2012 second_quarter PHA S. 1882, The Fair and Immediate Release of Generics Act S. 27, the Preserve Access to Affordable Pharmaceuticals Act HR 4332, the Generic Drug Application Review Fairness Act Amending Section 505(j) of the Food, Drug and Cosmetic Act, concerning the ability of generic pharmaceutical manufacturers to file counterclaims seeking the correction of incorrect patent information submitted to FDA's Orange Book by patent owners of New Drug Applications Supreme Court consideration of Novo Nordisk A/S and Novo Nordisk Inc. vs Caraco Pharmaceutical Laboratories Ltd. and Sun Pharmacuetical Industries Ltd. S. 2516, the Food and Drug Innovation and Safety Act: Title VIII, Generating Antibiotic Incentives, Title XI, Other Provisions, Section 1131, Drug Development and Testing HR 5651. the Food and Drug Administration Reform Act: Title VIII, Drug Regulatory Improvements, Subtitle F, Miscellaneous, Section 862, Extension of period for first applicant to obtain tentative approval without forfeiting 180-day exclusivity period, Section 863, Final agency action relating to petitions and civil actions S. 3187.PCS/.ES, the Food and Drug Administration Safety and Innovation Act: Title XI, Other Provisions, Subtitle C, Miscellaneous Provisions, Section 1131, Drug Development and Testing S AMDT 2111 to S. 3187, concerning pharmaceutical market blockages caused by parked 180 day exclusivity periods S. 3187.EAH, the Food and Drug Administration Safety and Innovation Act: Title XI, Other Provisions, Subtitle C, Miscellaneous Provisiosn, Section 1133, Extension of period for first applicant to obtain tentative approval without forfeiting 180 day exclusivity period, Section 1135, Final agency action related to petitions and civil actions Establishment of a federal track and trace system for pharmaceuticals Congressional Budget Office (CBO),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2012-07-13T09:41:12.413000-04:00
1261670 WINSTON & STRAWN LLP 42b19de4-efe1-468d-91d9-0a4af379fd65 Q2 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2012 second_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-13T10:48:55.073000-04:00
1261813 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 35696117-910e-45d2-ab68-9ed02e21d959 Q2 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 TEVA PHARMACUETICALS USA 2012 second_quarter PHA PDUFA and user fees issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-13T11:42:00.677000-04:00
1261841 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC a599942f-07d9-409e-8c48-f99794bf228b Q2 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 WOCKHARDT USA LLC 2012 second_quarter PHA Issues in PDUFA; preemption under FDA Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-13T11:52:16.733000-04:00
1262597 BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ 55299366-0083-466e-b8f7-7f62825590e4 Q2 BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ 5153 THE MEDICINES COMPANY 2012 second_quarter PHA Regulatory and Reimbursement Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2012-07-13T19:19:17.040000-04:00
1263473 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 296b5ec1-0dac-4d80-983e-bded5afb8e65 Q2 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 11003 COUNCIL FOR CITIZENS AGAINST GOVERNMENT WASTE 2012 second_quarter PHA H.R. 5651, legislation that would reauthorize and modify the Food and Drug Administrations (FDA) prescription drug and medical device user-fee programs; all sections HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2012-07-16T08:17:40.327000-04:00
1264028 GRIZZLE COMPANY 09867d49-61cf-4ce5-99e4-7bc98463e2a6 Q2 GRIZZLE COMPANY 16987 KENTUCKYONE HEALTH (FORMERLY JEWISH HOSPITAL HEALTH CARE SERVICES) 2012 second_quarter PHA S.3187, The Food and Drug Administration Safety and Innovation Act (FDASIA): Support provision to give FDA enhanced authority to address drug shortages. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-16T13:02:49.467000-04:00
1264373 EVERTZ GROUP LLC 066281c1-74b3-46a9-82e7-e9da961a5b10 Q2 EVERTZ GROUP LLC 400497446 MYLAN INC. 2012 second_quarter PHA Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) 30000   0 0 2012-07-16T15:00:38.377000-04:00
1264634 STEVE BUYER GROUP 09551281-9865-4860-811d-9d53555da353 Q2 STEVE BUYER GROUP 400701097 OMNICARE 2012 second_quarter PHA Advocacy in support of S 1560 promoting changes to the Controlled Substance Act providing access to pain medication for nursing. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-07-16T16:06:04.020000-04:00
1264749 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 93ead602-b34d-416f-9d98-8723c2035f98 Q2 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2012 second_quarter PHA S. 3187, H.R. 5651, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars, drug safety, expansion of over the counter (OTC) medicines. Communications to Health Resources and Services Administration on 340B drug discount program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2012-07-16T16:37:00.713000-04:00
1264821 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7ce30cde-4670-4055-b9c3-f12f89394f7b Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 second_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 5000   0 0 2012-07-16T16:46:36.520000-04:00
1264861 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. fb172deb-3185-4363-8eb0-675d68616c1e Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2012 second_quarter PHA Issues related to drug shortages. S.296/HR2245 Preserving Access to Life Saving Medications Act, HR3839 Drug Shortage Prevention Act; S.3187, FDA Safety and Innovation Act. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-07-16T16:55:51.250000-04:00
1264888 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2fe1967b-9f42-46b5-9c0c-65b2776de717 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2012 second_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. S.3187, FDA Safety and Innovation Act. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2012-07-16T17:00:00.737000-04:00
1264898 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 68b3ec4a-79da-4c60-b969-667475df10d6 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2012 second_quarter PHA Issues realted to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-16T17:06:06.330000-04:00
1265012 MCDERMOTT WILL & SCHULTE LLP 1fde7ce9-244b-49b6-af75-b2d7f5654044 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ISIS PHARMACEUTICALS 2012 second_quarter PHA Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-16T17:35:55.847000-04:00
1265408 EXPRESS SCRIPTS, INC. 63e869a8-390e-4000-a39a-7f06945aff1b Q2 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2012 second_quarter PHA Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 979); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); legislation to promote generic drugs (S. 27); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; legislation placing restrictions on pharmacy benefit design (HR 1971, S 1058). FDA Safety and Innovation Act: S. 3187, H.R.3988, H.R.4087, H.R.5334, S.2236, S.2289, S.2516: issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,White House Office   470000 0 0 2012-07-17T09:41:51.390000-04:00
1265430 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 29734739-0bdc-401a-9a68-93f4ef555fd2 Q2 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3446 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2012 second_quarter PHA Prescribing and Dispensing of Controlled Substances under the Controlled Substances Act; Health IT; Pharmacy Student Loan Repayment; Medication Use in Long-Term Care Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-17T09:54:57.600000-04:00
1265479 HARLOW GOVERNMENT RELATIONS LLC 9124828c-6b9f-4c26-a8d1-a0807aeb01a3 Q2 HARLOW GOVERNMENT RELATIONS LLC 400745232 AMERICAN MEDICAL ASSOCIATION 2012 second_quarter PHA online pharmacy regulation/registration HOUSE OF REPRESENTATIVES,SENATE 67500   0 0 2012-07-17T10:06:29.500000-04:00
1266274 MCDERMOTT WILL & SCHULTE LLP 758b9c7d-3956-4012-8ca3-48445fcbea28 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2012 second_quarter PHA Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-17T13:26:47.187000-04:00
1266561 MCDERMOTT WILL & SCHULTE LLP dea865cf-35d4-4bcf-a3f8-98acb2d3db3b Q2 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2012 second_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 200000   0 0 2012-07-17T14:31:28.360000-04:00
1266620 RICCHETTI INCORPORATED 9b0b8931-6c72-4649-af02-4409ba2a69cd Q2 RICCHETTI INCORPORATED 62778 ELI LILLY AND COMPANY 2012 second_quarter PHA issues related to pediatric exclusivity policy issues related to PDUFA reauthorization HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2012-07-17T14:44:23.143000-04:00
1266685 RICCHETTI INCORPORATED 11bdf878-3b0c-4777-985f-123ba8f91412 Q2 RICCHETTI INCORPORATED 62778 SANOFI-AVENTIS U S INC 2012 second_quarter PHA issues relating to PDUFA reauthorization HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) 30000   0 0 2012-07-17T15:04:29.033000-04:00
1266910 AMERICAN ACADEMY OF FAMILY PHYSICIANS 3d5b0aa3-0c23-46c2-adda-8ffe1f618d86 Q2 AMERICAN ACADEMY OF FAMILY PHYSICIANS 1342 AMERICAN ACADEMY OF FAMILY PHYSICIANS 2012 second_quarter PHA No Bill Number, Proposal to create "Special medical use" category of prescription drugs, Should FDA create category of drugs that non physicians like pharmacists could prescribe. No Bill Number, National Priorities and Research Agenda, PCORI should focus research on more common medical conditions first. Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE,White House Office   767597 0 0 2012-07-17T15:48:09.030000-04:00
1266935 NOVO NORDISK INC. 02d5deb7-3886-426a-8880-562449a5733d Q2 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2012 second_quarter PHA P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,White House Office   900000 0 0 2012-07-17T15:55:24.767000-04:00
1266950 THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA 479d3dcc-61bc-44fc-87c1-20072bb63d33 Q2 THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA 18672 HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA 2012 second_quarter PHA H.R. 5651, Food and Drug Administration Reform Act of 2012 S.3187, Food and Drug Administration Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2012-07-17T15:56:29.047000-04:00
1267068 VENABLE LLP 7afd5a90-2378-486b-b1c9-9687ed1de9a8 Q2 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2012 second_quarter PHA General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act; H.R. 5651.) The Life Sciences Investment Act (S. 1410; H.R. 2632) HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-07-17T16:14:17.010000-04:00
1267396 WHITMER & WORRALL, LLC 95751c7b-7534-4a29-84cd-48d8f27f0c04 Q2 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 second_quarter PHA Issues related to monitoring healthcare reform. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-17T17:01:50.593000-04:00
1267638 SQUIRE PATTON BOGGS fe8197fb-12e7-471d-9825-b7339bc08a2f Q2 SQUIRE PATTON BOGGS 30906 KV PHARMACEUTICAL COMPANY 2012 second_quarter PHA Issues regarding Medicaid coverage of Makena and regulatory treatment of Makena. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-17T18:00:42.823000-04:00
1267789 SQUIRE PATTON BOGGS ce747526-546f-4ade-a9d8-2d73eea857da Q2 SQUIRE PATTON BOGGS 30906 RANBAXY INC. 2012 second_quarter PHA S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; Prescription Drug User Fee Reauthorization issues. HOUSE OF REPRESENTATIVES,SENATE 180000   0 0 2012-07-17T18:36:00.367000-04:00
1267998 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) f43530a9-5181-4df2-910e-b128b8ec9cfe Q2 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2012 second_quarter PHA Importation of Prescription Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Presecription Drug Monitoring Programs (S. 2254/H.R. 4292/S. 3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S.1002/H.R. 4223); Import Safety(S.1584); Counterfeit Drugs(S.1886/H.R. 3668/S.3187); Internet Pharmacy(S.2002/H.R. 4095) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   323000 0 0 2012-07-18T08:58:02.590000-04:00
1268039 POLICY DIRECTIONS INC. cbdb8eb4-78f5-482b-aa9b-9f689754149f 2T POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2012 second_quarter PHA Antibiotics in animal foods Drug approvals Drugs in animal foods Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2012-07-18T09:21:22.747000-04:00
1268212 OMNICARE, INC. f7c9c44c-09e9-4760-9829-ac3ffe6d4bad Q2 OMNICARE, INC. 321112 OMNICARE INC 2012 second_quarter PHA Antipsychotic drug use in nursing homes Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2012-07-18T09:58:43.037000-04:00
1268535 BROWN RUDNICK LLP 21ebd700-4467-4f7b-bb9d-36fd593da921 Q2 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2012 second_quarter PHA Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R. 5651 & S. 2516 & S.3187 to drug shortages HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-18T10:55:20.507000-04:00
1268782 CARPI & CLAY, INC 0f829e04-d294-4c04-8970-26600f242a31 Q2 CARPI & CLAY, INC 35640 PACKARD CHILDREN'S HOSPITAL AT STANFORD 2012 second_quarter PHA H.R. 4274 BEST Pharmaceuticals for Children Act and Pediatric Research Equity Act; FDA Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-18T11:28:06.237000-04:00
1268854 CARPI & CLAY, INC 49f6b68a-f3b0-4fcf-bcd2-04765860f939 Q2 CARPI & CLAY, INC 35640 STANFORD HEALTH CARE 2012 second_quarter PHA Prescription Drug User Fee Act; legislation related to drug shortages (S. 296, H.R. 2245); FDA Safety and Innovation Act HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-18T11:36:42.940000-04:00
1269186 FORGE FEDERAL AFFAIRS LLC e3b06ca2-8a94-4033-8f32-6154a52d3829 Q2 FORGE FEDERAL AFFAIRS LLC 400865535 LILLY USA LLC 2012 second_quarter PHA Issues related to Prescription Drug User Fee Act (PDUFA). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-18T12:14:56.257000-04:00
1269398 COVIDIEN LP 033b1305-e8d0-4e5a-bc49-91f94f2762a3 Q2 COVIDIEN LP 319778 COVIDIEN LP 2012 second_quarter PHA Issues involving controlled substance and pain and addiction drugs generally; H.R. 2119: Ryan Creedon Act of 2011; Issues related to acetaminophen Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   440000 0 0 2012-07-18T12:50:30.033000-04:00
1269787 GREATER NEW YORK HOSPITAL ASSOCIATION f5fe231e-e287-464f-bb21-f6d4ed655062 Q2 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2012 second_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   220000 0 0 2012-07-18T13:32:58.727000-04:00
1269837 MICHAEL L. TINER f5efb0c9-41d0-4387-b258-bb8cdb10b6c2 Q2 MICHAEL L. TINER 38175 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2012 second_quarter PHA FDA Reauthorization Pharmaceutical Industry Employment Issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-07-18T13:44:15.670000-04:00
1270044 EISAI INC. 1d7aef5b-2920-46f1-9f7e-2b1a141e2a69 Q2 EISAI INC. 400321512 EISAI INC. 2012 second_quarter PHA Food and Drug Administration-Drug Enforcement Agency coordination and scheduling issues drug importation Prescription Drug User Fee Act reauthorization (HOPE Act, supply chain integrity) HOUSE OF REPRESENTATIVES,SENATE   610000 0 0 2012-07-18T14:18:24.803000-04:00
1270160 OCHSNER CLINIC FOUNDATION bd14dc30-8a77-4759-8ca1-7269c892fea7 Q2 OCHSNER CLINIC FOUNDATION 45391 OCHSNER CLINIC FOUNDATION 2012 second_quarter PHA S. 296 A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages. All Provisions. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2012-07-18T14:32:15.980000-04:00
1270264 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 007b0088-a962-4c26-9c07-dc316e0b4b00 Q2 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2012 second_quarter PHA S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; Sought Congressional support for the FTC investigation of the merger between two major national PBMs; SEE ADDENDUM S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security; Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in National Defense Authorization Act for FY2013; Medicare Part B Revalidation; S. 3376, PACT Act, Hydrocodone issues Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   340000 0 0 2012-07-18T14:45:56.750000-04:00
1270326 POWERS PYLES SUTTER & VERVILLE, P.C. 2b8eb2f5-0ed5-49fa-94cc-73176f576b53 Q2 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 340B HEALTH 2012 second_quarter PHA Section 340B of the Public Health Service Act, Section 1927 of the Social Security Act and issues related to (1) administration of the 340B Drug Discount Program, (2) implementation of 340B-related provisions in the Patient Protection and Affordable Care Act of 2010, (3) funding of the Health Resources and Services Administration (HRSA) under the FY2012 Labor Health & Human Services & Education appropriations bills, and (4) enactment of the 340B Program Improvement Act of 2011 (H.R. 2674). Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-07-18T14:57:26.337000-04:00
1270350 KNIGHT CAPITOL CONSULTANTS d5ab8734-5d32-4d1b-8dad-fd2bbd21cc1f Q2 KNIGHT CAPITOL CONSULTANTS 40036301 GENZYME CORPORATION 2012 second_quarter PHA S. 606, Creating Hope Act of 2011, S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act Reauthorization of the Prescription Drug User Fee Act (H.R. 5651/S. 3187) H.R. 4132, Faster Access to Specialized Treatments Act/S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatment (TREAT) Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-18T15:00:36.317000-04:00
1270814 FAEGRE BAKER DANIELS CONSULTING e46725e6-adf0-4667-8d13-b435770d62e9 Q2 FAEGRE BAKER DANIELS CONSULTING 34158 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) 2012 second_quarter PHA Online Pharmacies Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-07-18T15:54:19.760000-04:00
1270975 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 7c3cf38a-d370-47f4-8f68-f1e028c6785d Q2 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2012 second_quarter PHA H.R. 1409: All provisions of the Quality Health Care Coalition Act of 2011; H.R. 891/S. 274: All provisions of the Medication Therapy Management Benefits Act of 2011; H.R. 905 /S. 733:All provisions of the legislation to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare; H.R. 979 - All provisions of the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 605 / S. 312 -All provisions of the Patients Freedom to Choose Act S. 27 - All provisions of the Preserve Access to Affordable Generics Act S. 31 - All provisions of the Prescription Drug and Health Improvement Act of 2011 S. 44 -All provisions of the Medicare Prescription Drug Price Negotiation Act of 2011 H.R. 999 / S. 560 - All provisions of the Medicare Prescription Drug Savings and Choice Act of 2011 H.R. 1839 - All provisions of the Community Pharmacy Fairness Act of 2011; H.R. 1946 - All provisions of the Preserving or Hometown Independent Pharmacies Act of 2011; H.R. 1971 / S. 1058 - All provisions of the Pharmacy Competition and Consumer Choice Act of 2011 Provisions of PL 111-148 and PL 111-152 impacting Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap Regulatory design and coverage of pharmacy benefits in health reform exchanges and the commercial market (essential health benefits, grandfathering, value-based insurance design, e-prescribing, PBM disclosure requirements, and medical loss ratio) Regulatory and proposed legislative changes to Medicare part D including EGWP waivers, MTM expansion, long term care short-term fills, recovery audit contractors Implementation of changes to the definition of Average Manufacturer Price in Medicaid Issues related to the management of Medicaid prescription drug benefits Legislation to promote generic drugs FDA issues related to the Prescription Drug User Fee Act (PDUFA) (generic user fees, pedigree, REMs); implementation of… Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE   520388 0 0 2012-07-18T16:16:37.717000-04:00
1271073 UPS (UNITED PARCEL SERVICE) 259f1fc5-d6bc-40ca-823c-368f4658191e Q2 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2012 second_quarter PHA - S. 3187 Food & Drug Administration Safety Innovation Act / HR 5651 Food and Drug Administration Reform Act of 2012 - Healthcare Supply Chain Safety - track and trace in the Prescription Drug Users Fee Act Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Postal Service (USPS),U.S. Trade Representative (USTR),White House Office   1205303 0 0 2012-07-18T16:24:09.123000-04:00
1271862 GOVBIZ ADVANTAGE, INC. 078151ec-9507-46f4-8952-52fce32945dd Q2 GOVBIZ ADVANTAGE, INC. 294234 CATALYST HEALTH SOLUTIONS (CATAMARANRX) 2012 second_quarter PHA Pharmacy Benefit Issues in health legislation; PBM issues; General company congressional relations; business issues; oversight of PBMs HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-18T18:52:40.493000-04:00
1272260 VAN SCOYOC ASSOCIATES b37f62b3-1b93-4960-b3fb-a8e81fed7567 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2012 second_quarter PHA Issues related to FDA salaries and expenses; and extramural research: S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013 Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012 Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-19T07:00:24.287000-04:00
1272270 VAN SCOYOC ASSOCIATES d3ef0c59-18b5-4cc6-bfc3-2ee664594ead Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2012 second_quarter PHA FDA funding initiatives; Critical Path Partnership. S.2375/H.R.5973, Agriculture,Rural Development,Food and Drug Administration,and Related Agencies Appropriations Act, FY2013 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012 Monitor Prescription Drug User Fee Act (PDUFA) SENATE 50000   0 0 2012-07-19T07:01:26.270000-04:00
1272282 RUBICON ADVISORS, LLC b4cb377c-9efb-48dc-a797-bea0d9fa0e26 Q2 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2012 second_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-19T07:14:30.977000-04:00
1272286 RUBICON ADVISORS, LLC 0d76f160-ca11-40a9-8faf-60afc26b9374 Q2 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2012 second_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2012-07-19T07:18:33.157000-04:00
1272287 RUBICON ADVISORS, LLC 0ad4e1cb-2d80-4a78-b793-9452a84a8cf3 Q2 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2012 second_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2012-07-19T07:22:34.463000-04:00
1272288 RUBICON ADVISORS, LLC f744500b-0315-4411-9efc-7684512ec227 Q2 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2012 second_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 HOUSE OF REPRESENTATIVES,SENATE 98000   0 0 2012-07-19T07:25:35.157000-04:00
1272308 AARP c17c2eb4-7d89-4102-a346-edba1bdb981d Q2 AARP 1694 AARP 2012 second_quarter PHA Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act - Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468, Discussed counter… Administration on Aging,Agriculture, Dept of (USDA),Bureau of the Census,Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Energy Regulatory Commission (FERC),Federal Highway Administration (FHA),Federal Reserve System,Federal Trade Commission (FTC),Federal Transit Administration (FTA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Highway Traffic Safety Administration (NHTSA),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   2740000 0 0 2012-07-19T08:30:57.857000-04:00
1272559 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION c272b597-d709-4045-83d1-91ffd553308e Q2 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2012 second_quarter PHA Over-the-Counter (OTC) medicines; Manufacturing and importation of OTC drugs; mandatory recall authority of the FDA; Rx-to-OTC Switch H.R. 1483 - Drug Safety Enhancement Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand drug establishment registration requirements to include foreign drug establishments and other purposes; all sections. S. 1584 - Drug Safety and Accountability Act of 2011. Amends the federal Food, Drug, and Cosmetic Act (FDCA) to expand registration requirements for drug manufacturers, wholesalers, distributors, and retailers; grants FDA mandatory recall authority; requires adequate documentation of the pharmaceutical supply chain; all sections. House and Senate drafts of Prescription Drug User Fee Act (PDUFA). Reauthorizes the Food and Drug Administration (FDA) to collect user fees from pharmaceutical on over-the-counter drug manufacturers; all sections (H.R. 5651/S. 3187). Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   183564 0 0 2012-07-19T09:46:30.007000-04:00
1272719 SQUIRE PATTON BOGGS (US) LLP (F.K.A. SQUIRE SANDERS (US) LLP) 1bd671ad-0350-4dec-887a-852b53cfd6ac Q2 SQUIRE PATTON BOGGS (US) LLP (F.K.A. SQUIRE SANDERS (US) LLP) 55223 COVERMYMEDS 2012 second_quarter PHA Prescription drug prior authorizations and other insurance coverage determinations Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS)     0 0 2012-07-19T10:16:42.227000-04:00
1272763 VAN SCOYOC ASSOCIATES 035a0abd-2a07-474d-ab2a-8ab467e6beab Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2012 second_quarter PHA S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013, FDA initiatives; and Critical Path initiative. S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act, FDA initiatives; Critical Path issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-07-19T10:22:03.487000-04:00
1273143 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES af7f0b36-4e81-43bd-818a-2a06cdb749a2 Q2 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 2321 AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES 2012 second_quarter PHA S 3187 - Food and Drug User Fee Program Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Treasury, Dept of,White House Office   670000 0 0 2012-07-19T11:06:47.007000-04:00
1273358 THE DUBERSTEIN GROUP INC. caa844cd-bc52-48b4-aad7-2d0ac659e9a8 Q2 THE DUBERSTEIN GROUP INC. 12675 AMERICA'S HEALTH INSURANCE PLANS 2012 second_quarter PHA *FEHBP prescription drugs - HR 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. *Pay-for-delay settlements - S 27, Preserve Access to Affordable Generics Act. *Antitrust exemption for independent pharmacies - HR 1946, Preserving Our Hometown Independent Pharmacies Act of 2011. *FDA user fee programs - HR 3988, Generic Drug and Biosimilar User Fee Act of 2012. *Pay-for-delay settlements - HR 3995, Protecting Consumer Access to Generic Drugs Act of 2012. *FDA oversight of medical devices - S 2193, Ensuring Safe Medical Devices for Patients. *Pharmaceutical, medical device issues - HR 5651, Food and Drug Administration Reform Act of 2012; S 2516, Food and Drug Administration Safety and Innovation Act; S 3187, Food and Drug Administration Safety and Innovation Act. *Standards for on-line pharmacies - S 2002, Online Pharmacy Safety Act. HOUSE OF REPRESENTATIVES 100000   0 0 2012-07-19T11:21:11.167000-04:00
1273662 THE DUBERSTEIN GROUP INC. fc77c288-0941-4bf5-94bc-508a3a1f4944 Q2 THE DUBERSTEIN GROUP INC. 12675 PFIZER INC. 2012 second_quarter PHA Drug shortages - Proposed legislation re these issues. Opiate abuse - HR 1316, Stop Oxy Abuse Act of 2011; HR 2119, Ryan Creedon Act of 2011; HR 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011; HR 1065, Pill Mill Crackdown Act of 2011; S 507, Prescription Drug Abuse Prevention and Treatment Act of 2011; Executive Branch action re this issue. Pharmaceutical issues, including tracking and tracing medicines, fostering competition between generic and brand-name pharmaceutical manufacturers - HR 5651, Food and Drug Administration Reform Act of 2012; S 3187, Food and Drug Administration Safety and Innovation Act. Incentives to develop antibiotics - HR 2182, Generating Antibiotic Incentives Now Act of 2011; S 1734, Generating Antibiotic Incentives Now Act of 2011. Establish criminal penalties for trafficking in counterfeit drugs - HR 3468, Counterfeit Drug Penalty Enhancement Act of 2011; S 1886, Counterfeit Drug Penalty Enhancement Act of 2011. National Center for Advancing Transformational Sciences at FDA; agreement to review compounds for potential new uses - Executive Branch actions re these issues. *Follow-on biologics generally. *Certified Importer Program. *Drug safety - HR 1483, Drug Safety Enhancement Act of 2011. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 100000   0 0 2012-07-19T11:47:19.007000-04:00
1273663 FIERCE, ISAKOWITZ & BLALOCK cf3f9ace-fec4-49b2-935d-f5a88627713e Q2 FIERCE, ISAKOWITZ & BLALOCK 44812 SUCAMPO PHARMACEUTICALS, INC. 2012 second_quarter PHA General FDA Issues HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-19T11:47:27.787000-04:00
1273811 NATIONAL PATIENT ADVOCATE FOUNDATION cd6ae624-e494-4d6e-b0a2-ae47d4b98e5c Q2 NATIONAL PATIENT ADVOCATE FOUNDATION 28311 NATIONAL PATIENT ADVOCATE FOUNDATION 2012 second_quarter PHA Prescription Drug user fee - drug shortage and breakthrough therapies     117181 0 0 2012-07-19T11:58:42.017000-04:00
1273923 BLUECROSS BLUESHIELD OF TENNESSEE 5e429515-2332-4475-a4dc-adfc481ee001 Q2 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2012 second_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2012-07-19T12:09:22.463000-04:00
1274039 TARPLIN, DOWNS & YOUNG, LLC 33c95072-6bdc-42d5-bec8-d5c04e861c4b Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2012 second_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act and associated policies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2012-07-19T12:23:10.987000-04:00
1274143 WINSTON & STRAWN LLP 9b775024-74ed-4fc6-ab2f-d79d42ff6f25 Q2 WINSTON & STRAWN LLP 41682 WOCKHARDT USA LLC 2012 second_quarter PHA Generic drug issues - federal preemption of state claims; FTC regulation of settlement agreements HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-07-19T12:33:57.497000-04:00
1274202 TARPLIN, DOWNS & YOUNG, LLC f0d29d5b-c4d6-4ea5-899c-3965e47aca06 Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2012 second_quarter PHA **see addendum page Importation of prescription drugs (S.319/H.R. 147) NASPER reauthorization (H.R. 866) Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297) Drug Abuse (S. 507) Drug Shortages (S. 296/H.R. 2245/H.R. 3839/S.3187/H.R. 5853/H.R. 5651) Rx Pedigree (H.R. 3026/S. 3187) Cargo/Product Theft (S. 1002/H.R. 4223) Import Safety (S. 1584) Drug Importation (H.R. 2112 - Agriculture, Transportation Appropriations Bill for 2012) Prescription Drug Monitoring Program (H.R. 2254/H.R. 4292/S. 3187) Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) Internet Pharmacey (S. 2002/H.R. 4095) ***, no specific bills: supply chain integrity, prescription drug abuse, internet pharmacy regulation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-07-19T12:37:13.847000-04:00
1274210 HANCE SCARBOROUGH 065e458e-b27b-46c9-a853-eaf1ace860b9 Q2 HANCE SCARBOROUGH 17443 INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) 2012 second_quarter PHA Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-07-19T12:38:18.817000-04:00
1274226 AMERICAN PHARMACISTS ASSOCIATION 2d55eec3-2ae5-4979-8ced-0a4b43de351f Q2 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2012 second_quarter PHA HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;transitions of care;pharmacy reibursement; loan forgiveness;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;personalized medication lists;ACOs;pharmacists role in CMS Innovation Center initiatives;standardized pharmacy notice;immunization;HIT; medication disposal;biosmiliars;EHB Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE     0 0 2012-07-19T12:40:26.670000-04:00
1274271 TARPLIN, DOWNS & YOUNG, LLC ab503529-9e72-4ddb-8f80-1b74695a1724 Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 ASTRAZENECA 2012 second_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act H.R. 2182/S. 1734 - Generating Antibiotics Incentives Now Act S. 3187 - The Food and Drug Administration Safety and Innovation Act (H.R. 3988, H.R. 4087, H.R. 5334, S. 2236, S. 2289, S. 2516) ***, no specific bill(s), Import Safety, Prescription Drug User Fee Act renewal, drug development policy, drug shortages, supply chain integrity, patent settlements Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-07-19T12:46:48.940000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1473.661ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API